Seattle-based biotech startup ZipBio announced its official launch on Thursday and revealed $4 million in a seed funding round led by NFX.
Founded last year, ZipBio is developing a platform that “compresses complex biological structures into smaller, more efficient de novo-designed proteins that retain full functionality, optimizing delivery and therapeutic effectiveness,” according to the company.
